What is the recommended dose of Ancef (cefazolin) for a 9-year-old male weighing 63 pounds with a facial laceration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefazolin Dosing for Facial Laceration in a 9-Year-Old, 63-Pound Male

For this 9-year-old male weighing 63 pounds (28.6 kg) with a facial laceration, administer cefazolin 33 mg/kg/dose IV every 8 hours, which equals approximately 950 mg per dose (can round to 1 gram for practical administration). 1

Weight-Based Calculation

  • Patient weight: 63 pounds = 28.6 kg
  • Recommended pediatric dosing: 33 mg/kg/dose every 8 hours for skin and soft tissue infections 1
  • Calculated dose: 28.6 kg × 33 mg/kg = 943 mg per dose (round to 1 gram for ease of administration)
  • Frequency: Every 8 hours 1

Rationale for This Dosing

  • Cefazolin is the preferred first-generation cephalosporin for skin and soft tissue infections caused by methicillin-susceptible Staphylococcus aureus (MSSA), which is the most common pathogen in traumatic skin injuries like facial lacerations 1
  • The FDA-approved pediatric dosing range is 25-50 mg/kg/day divided into 3-4 doses for mild to moderate infections, with up to 100 mg/kg/day for severe infections 2
  • The 33 mg/kg/dose every 8 hours (approximately 100 mg/kg/day total) falls within the higher end of the recommended range, appropriate for ensuring adequate tissue penetration in facial wounds 1

Duration of Therapy

  • For uncomplicated facial lacerations, a short course is typically sufficient (generally 5-7 days or until clinical improvement is evident) 1
  • Do not extend therapy unnecessarily beyond clinical indication to avoid antimicrobial resistance 1

Administration Considerations

  • For IV bolus administration: Reconstitute and further dilute with approximately 5 mL Sterile Water for Injection, then inject slowly over 3-5 minutes 2
  • For intermittent infusion: Dilute in 50-100 mL of compatible solution (0.9% sodium chloride or 5% dextrose) 2
  • Administer 30-60 minutes before any surgical repair if wound closure is planned 3

Important Clinical Caveats

  • Penicillin allergy is NOT a contraindication to cefazolin in most cases, as cross-reactivity between penicillin and cefazolin is extremely low due to different R1 side chains 4
  • Only avoid cefazolin if the patient has a history of severe delayed hypersensitivity reactions (Stevens-Johnson syndrome, hepatitis, nephritis, serum sickness, or hemolytic anemia) to penicillin 4
  • Assess renal function: If creatinine clearance is reduced, dosing adjustments may be needed, though this is uncommon in healthy 9-year-olds 2
  • For facial wounds specifically, ensure adequate coverage against S. aureus and Streptococcus pyogenes, both of which are well-covered by cefazolin 3

Alternative Considerations

  • If MRSA is suspected based on local epidemiology or patient risk factors (prior MRSA infection, recent hospitalization), consider adding vancomycin or switching to clindamycin 3
  • For contaminated wounds with soil or animal exposure, broader coverage may be needed, but for simple facial lacerations, cefazolin monotherapy is appropriate 3

References

Guideline

Cefazolin Dosing for Pediatric Patients with Skin and Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.